Seiji Niho
Impact in
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Medical Imaging and Pathology Studies
- Oncology top 2%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
-
- Lung Cancer Treatments and Mutations 44
- Lung Cancer Diagnosis and Treatment 29
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 5
- Oncology 46
- Lung Cancer Research Studies 30
- Cancer Immunotherapy and Biomarkers 12
- Co-authors
- Kōichi Goto (91 shared papers)Kiyotaka Yoh (83 shared papers)Hironobu Ohmatsu (65 shared papers)Yutaka Nishiwaki (31 shared papers)Genichiro Ishii (35 shared papers)Shingo Matsumoto (51 shared papers)Shigeki Umemura (47 shared papers)Kaoru Kubota (31 shared papers)
- Journals
- Lung Cancer (29 papers)Annals of Oncology (21 papers)Journal of Thoracic Oncology (15 papers)Japanese Journal of Clinical Oncology (13 papers)Journal of Cancer Research and Clinical Oncology (8 papers)
- Partner nations
- JapanUnited StatesSouth Korea
In The Last Decade
Seiji Niho
172 papers receiving 5.7k citations
Seiji Niho's Hit Papers
Peers
Comparison fields: 5 of 76
- Pulmonary and Respiratory Medicine 2.5k
- Oncology 1.0k
- Neurology 305
- Drug Discovery 1
- Pharmacology 82
Countries citing papers authored by Seiji Niho
This map shows the geographic impact of Seiji Niho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seiji Niho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seiji Niho more than expected).
Fields of papers citing papers by Seiji Niho
This network shows the impact of papers produced by Seiji Niho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seiji Niho. The network helps show where Seiji Niho may publish in the future.
Co-authors
The 25 scholars most cited alongside Seiji Niho, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 185 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial Hit paper breakdown → | 2017 | 998 |
| 2 | Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib With Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer and EGFR-Activating Mutations Hit paper breakdown → | 2018 | 377 |
| 3 | 2012 | 166 | |
| 4 | 2020 | 164 | |
| 5 | 2016 | 162 | |
| 6 | 2014 | 152 | |
| 7 | 2013 | 134 | |
| 8 | 2005 | 132 | |
| 9 | 2004 | 115 | |
| 10 | 2014 | 109 | |
| 11 | 2008 | 97 | |
| 12 | 2020 | 93 | |
| 13 | 2018 | 92 | |
| 14 | 2019 | 80 | |
| 15 | 2019 | 79 | |
| 16 | Monoclonality of both pale cells and cuboidal cells of sclerosing hemangioma of the lung. | 1998 | 77 |
| 17 | 1999 | 77 | |
| 18 | 2003 | 74 | |
| 19 | 2003 | 72 | |
| 20 | 2004 | 70 |
About Seiji Niho
Seiji Niho is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Neurology, Pharmacology and Pathology and Forensic Medicine, having authored 185 papers that have together received 5.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (44 papers), Lung Cancer Research Studies (30 papers), Lung Cancer Diagnosis and Treatment (29 papers), Cancer Immunotherapy and Biomarkers (12 papers), Myasthenia Gravis and Thymoma (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Chemotherapy-induced organ toxicity mitigation (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.5k citations), Oncology (1.0k citations), Neurology (305 citations), Drug Discovery (1 citation) and Pharmacology (82 citations). Seiji Niho has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Kōichi Goto, Kiyotaka Yoh, Hironobu Ohmatsu, Yutaka Nishiwaki, Genichiro Ishii, Shingo Matsumoto, Shigeki Umemura, Kaoru Kubota, Yuichiro Ohe and Kazuhiko Nakagawa. Their work appears in journals such as Lung Cancer, Annals of Oncology, Journal of Thoracic Oncology, Japanese Journal of Clinical Oncology and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.